INTRODUCTION
============

The intravenous anesthetic propofol is widely used as an anesthetic in clinics and intensive care units. Circulatory suppression occurs after administration of propofol, which may involve decreased myocardial contractility and peripheral vascular resistance. Many studies have shown that propofol has direct effects on blood vessels, but the precise mechanism for these effects is not fully understood. Vasodilation effects of propofol have been demonstrated in several *in vitro* studies of blood vessels, including porcine coronary artery \[[@B1]\], rat aorta \[[@B2]\], pulmonary artery \[[@B3]\], coronary artery \[[@B4]\], renal artery \[[@B5]\], and fetal placental vessels \[[@B6]\]. In contrast, Edanaga \[[@B7]\] demonstrated that propofol increased rat pulmonary vascular resistance and attenuated acetylcholine-induced pulmonary vasodilation. Other studies claimed that propofol enhanced vasoconstriction\[[@B8]\]. Thus, the effect of propofol and its mechanism of action may vary with species and location of vessels. In this study, we used isolated rat secondary intrapulmonary artery rings to observe the effects of propofol on pulmonary vascular tone to deduce the possible mechanism of action and to provide laboratory data to guide clinical drug use.

METHODS
=======

Preparation of artery rings
---------------------------

This study was performed after obtaining permission from the ethics committee of our hospital. Healthy adult male Sprague-Dawley rats (provided by the animal laboratory at Sun Yat-sen University) weighing 200 to 300 g were anesthetized by intraperitoneal injection of pentobarbital sodium (150 mg/kg). The cardiopulmonary tissue was removed from each rat and placed into a container filled with ice cold Kreb\'s solution. Second order intrapulmonary small arteries were removed and cut into several rings about 1\~2 mm in length. Each ring was mounted in the chamber of a Multi Myograph System with two wires passing through the lumen. Each chamber contained 5 ml of Kreb\'s solution bubbled constantly with 95% O~2~ plus 5% CO~2~. The room temperature was maintained at 37℃ throughout the duration of the experiment. After an equilibration period of 60 min, each ring was stretched to an optimal tension of 2 mN, and each ring then was contracted by administration of 60 mmol/L K^+^ at 30 min intervals until two consecutive contractions occurred. Contractile ability of each ring was confirmed by visualization of good contraction after exposure to 60 mmol/L K^+^ solution. The Kreb\'s solution in the chambers was changed every 15 min during the equilibration period. In some rings, the endothelial layer was mechanically disrupted by gently rubbing a tiny wire back and forth over the luminal surface several times. Functional removal of the endothelial layer was verified by lack of a relaxant response to 1 µmol/L acetylcholine. U46619 and propofol were dissolved in the solvent dimethyl sulfoxide (DMSO). To make sure that the highest concentration of DMSO (1 : 500) did not affect the U46619- or high K^+^-induced vessel tone, several rings were contracted by U46619 or high K^+^, then DMSO at 1 : 500 concentration was added to the chamber.

Effects of propofol on vessels contracted by different vasoconstrictors
-----------------------------------------------------------------------

Endothelium-intact rings were contracted by administration of 60 mmol/L high K^+^ solution, 100 nmol U46619, 3 µmol/L 5-hydroxytryptamine (5-HT), or 1 µmol phenylephrine (Phe), and the contractile responses were recorded. If the response was more than 3 mN, cumulative doses of propofol (1 to 300 µmol/L) were added to the chambers; if not, the vasoconstrictors were cumulatively added to the chambers to make sure the dose was high enough to cause vasoconstriction.

The role of the endothelium on the vasodilation effect of propofol
------------------------------------------------------------------

Endothelium-intact rings were contracted with 100 nmol/L U46619, then propofol (1 to 300 µmol/L) was cumulatively added in the absence or presence of 1 nmol/L N^G^-nitro-L-arginine methyl ester (L-NAME). Endothelium-denuded rings were preconstricted with 100 nmol/L U46619. Propofol was added as described above.

The role of Ca^2+^ on the vasodilation effects of propofol
----------------------------------------------------------

The ability of propofol to modulate Ca^2+^ influx via the L-type Ca^2+^ channels was evaluated by examining concentration-dependent responses to CaCl~2~ (0.01 to 3 mmol/L) in the absence or presence of propofol (10 to 300 µmol/L). In this set of experiments, endothelium-intact rings were rinsed three times in a Ca^2+^-free solution containing 500 µmol/L of ethylene glycol tetraacetic acid (EGTA), then incubated in a Ca^2+^-free 60 mmol/L K^+^ (without or with propofol, 20 min preincubation) before cumulative addition of CaCl~2~. Other rings were preconstricted with 60 mmol/L K^+^ solution to open the voltage-gated Ca^2+^ channels, followed by the addition of 1 µmol/L nifedipine to block L-type voltage-gated Ca^2+^ channels. After the tone returned to the basal level, which indicated that most, if not all, of the L-type voltage-gated channels were blocked, the rings were recontracted with 100 nmol/L U46619. Cumulative doses (1 to 300 µmol/L) of propofol then were added to the chamber, and the relaxation curve was determined.

Data measurements
-----------------

Relaxation was calculated as the percentage of contractions induced by 60 mmol/L K^+^ or 100 nmol/L U46619. E~max~ represents the maximal response percentage. EC~50~ refers to the concentration of a drug that reduced (or increased) the maximal contraction by 50%. The negative logarithm of the dilator (or contractor) concentration that resulted in half of the maximal relaxation or contraction (pD~2~) was calculated. Curves were analyzed by non-linear curve fitting using Graphpad software (Version 3.0).

Data analysis
-------------

The software SPSS 13.0 was used to conduct statistical analyses. Results are shown as mean±S.E.M of *n* arterial rings. The paired student\'s t-test was used to assess the effects of propofol on preconstricted rings in the absence or presence of L-NAME. The independent Student\'s t-test was used to analyze the effects of propofol on preconstricted rings with or without endothelium. One-way ANOVA followed by the LSD test was used when more than two groups were compared. p\<0.05 was considered to be statistically significant.

RESULTS
=======

Effects of different vasoconstrictors on isolated rat intrapulmonary arteries
-----------------------------------------------------------------------------

Administration of 60 mmol/L high K^+^ solution or 100 nmol/L U46619 caused strong contraction of isolated second order rat intrapulmonary arteries, but the effects of 5-HT or Phe were very weak, even when very high concentrations of 5-HT (10 µmol/L) or Phe (30 µmol/L) were used ([Table 1](#T1){ref-type="table"}).

Effects of propofol on non-receptor-dependent and receptor-dependent vasoconstrictors
-------------------------------------------------------------------------------------

Propofol relaxed rings preconstricted by both the high K^+^ (non-receptor-dependent vasoconstrictor) solution and U46619 (receptor-dependent vasoconstrictor) in a concentration-dependent manner ([Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). The maximal relaxant effect of propofol on the high K^+^-preconstricted rings was 97.57±2.05% and pD~2~ was 4.38±0.08; in the U46619-preconstricted rings, Emax was 88.18±10.33% and pD~2~ was 4.15±0.27 ([Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}).

The role of endothelium on propofol-induced relaxation
------------------------------------------------------

Propofol induced relaxation of U46619-mediated contraction in both endothelium-intact and endothelium-denuded rings in a concentration-dependent manner ([Figs. 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Results showed that 1 µmol/L L-NAME incubation did not affect propofol-induced maximal relaxation in endothelium-intact rings, but it did affect the value of pD~2~ (relaxation: 82.60±22.15% in control, 77.62±26.58% in L-NAME, n=5, p=0.213; pD~2~: 4.21±0.26 in control, 4.01±0.28 in L-NAME, n=5, p=0.012). Propofol induced a similar degree of relaxation of both endothelium-intact and endothelium-denuded U46619-preconstricted rings (relaxation: 82.60±22.15% with endothelium and 86.27±18.37% without endothelium, p=0.783; pD~2~: 4.21±0.26 with endothelium and 4.41±0.36 without endothelium, p=0.343).

Effect of propofol on Ca^2+^ channels
-------------------------------------

Different concentrations of propofol (10 to 300 µmol/L) were tested to evaluate their effect on CaCl~2~ induced contractions. Cumulative addition of CaCl~2~ induced contractions in the Ca^2+^-free 60 mmol/L K^+^ solution in the absence (n=5) and presence of propofol (10 to 300 µmol/L, n=5). Propofol inhibited CaCl~2~-induced contraction with progressive reduction of maximal contraction with increasing concentrations (p=0.000), but the pD~2~ value did not differ significantly between groups. Propofol at 100 and 300 µmol/L totally inhibited CaCl~2~-induced contraction ([Fig. 5](#F5){ref-type="fig"}).

Preconstriction of rings by administration of 60 mmol/L K^+^ could be fully reversed by the addition of 1 µmol/L nifedipine, which indicates that the L-type Ca^2+^ channel was fully inhibited. A high concentration of K^+^ in the extracellular bath causes membrane depolarization, which opens voltage-gated L-type Ca^2+^ channels and results in vascular contraction. After the inhibition of L-type Ca^2+^ channels with nifedipine, subsequent addition of U46619 could still induce contraction. Cumulative addition of propofol (1 to 300 µmol/L) caused a concentration-dependent inhibition of U46619-induced contraction (Emax=88.97±5.60%).

DISCUSSION
==========

The main findings of the present study were as follows: (1) Isolated rat intrapulmonary arteries exhibited a strong contractile response when they were exposed to high K^+^ solution and U46619; (2) propofol induced both non-receptor-dependent and receptor-dependent contraction; (3) propofol relaxed U46619 preconstricted pulmonary rings in an endothelium-independent manner; and (4) the mechanism for these responses may involve an inhibition of influx of extracellular Ca^2+^ via voltage-operated calcium channels (VOCCs) and receptor-operated calcium channels (ROCCs). The first two findings have been reported previously and are generally accepted; although the second two findings have also been reported in the literature, they are controversial.

The advantage of the approach used in our study is that we used secondary intrapulmonary arteries, which are narrow vessels that are involved in pulmonary physiologic and pathogenic phenomena. Propofol is commonly used anesthetic, but its use is often accompanied by short-term circulatory suppression (e.g., hypotension or low heart rate) \[[@B8]\]. Propofol has direct effects on vessel tone, but the precise mechanism for this effect is not fully understood.

Solutions containing high K^+^ or U46619 induced contraction of isolated rat intrapulmonary arteries, but 5-HT or Phe did not, even at high concentrations. Propofol induced relaxation of both non-receptor-dependent and receptor-dependent contraction, with great potency on KCl-induced contraction when the concentration of propofol accumulated to 300 µmol/L. U46619 is a thromboxane mimic. Thromboxane-A~2~ (TXA~2~) is an unstable prostanoid produced by thromboxane-A synthase. It acts on the TxA~2~ receptor to induce smooth muscle contraction. Increases of TXA~2~ in plasma reflect a disorder of endothelium function. Therefore, propofol may be a good anesthetic and vessel dilator in patients with endothelium function disorders.

The vascular endothelium produces many substances to modulate relaxation and contraction of vascular smooth muscles. Nitric oxide (NO) is one of the important endothelium-derived relaxing factors synthesized by NO synthase. NO activates dissoluble guanylate cyclase, which increases cAMP in vascular smooth muscle cells. cAMP downregulates intracellular Ca^2+^, which results in vascular smooth muscle relaxation. The NO synthase inhibitor L-NAME blocks NO synthase, thus reducing the production of NO. In the present study, propofol induced similar relaxation on both endothelium-intact and endothelium-denuded U46619 preconstricted rings, and no significant difference was observed between endothelium-intact rings in the absence or presence of L-NAME. These results show that the effect of propofol on preconstricted intrapulmonary artery rings likely does not occur through the endothelium. Wallerstedt et al. \[[@B9]\] found that propofol relaxed human omental arteries and veins in an endothelium-independent manner. Liu et al. \[[@B10]\] reported that propofol inhibited KCl-, norepinephrine-, and U46619-induced contractions of isolated rat renal arterioles, with greater inhibition of KCl-induced contraction, which may indicate that propofol inhibits contractions involved in inhibition of extracellular Ca^2+^ influx. Our study showed similar results.

Ca^2+^ plays a very important role in cellular function, and it also is involved in the pathogenesis of diseases such as pulmonary hypertension \[[@B11]\]. When the vascular smooth muscle contracts, the \[Ca^2+^\]~i~ increases mainly via VOCCs and ROCCs. VOCCs are activated by membrane depolarization in vascular smooth muscle cells when the extracellular K^+^ concentration is elevated \[[@B12]\]. In the present study, propofol significantly reduced CaCl~2~-induced vasoconstriction in the high K^+^ solution. This is direct evidence that propofol acts as antagonist on L-type Ca^2+^ channels in vascular smooth muscle isolated from rat intrapulmonary artery. Propofol also reduced U46619-elicited contraction, which indicates that propofol may inhibit TXA~2~-sensitive receptor-operated Ca^2+^ channels. Furthermore, when the artery rings were first incubated with nifedipine to block L-type Ca^2+^ channels, propofol also inhibited U46619-induced contraction in a dose-dependent manner. Thus, propofol may also act as a non-L-type Ca^2+^ channel blocker \[[@B13]\]. However, the exact mechanism of action of propofol on intrapulmonary arteries still requires further investigation.
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![The role of the endothelium on the vasodilation effect of propofolusing endothelium intact rings preconsricted by 100 mmol/L U46619. Responses are expressed as percentage of precontraction induced by 100 nmol/L U46619. Propofol indued relaxation in the absence or presence of L-NAME (the nitric oxide synthase inhibitor). No significant difference of E~max~ was observed in the absence or presence of L-NAME (n=5 for each group).](kjpp-18-377-g003){#F3}
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![CaCl2-induced contraction in Ca^2+^-free solution containing 60 mmol/L K^+^ in the absence (n=5) and presence of propofol (10 to 300 µmol/L, n=5). A significant difference in E~max~ between control and propofol-treated groups is indicated by an asterisk (p\<0.001).](kjpp-18-377-g005){#F5}
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Reaction of isolated rat secondary pulmonary artery to different vasoconstrictors (χ±s, n=4)
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mN represented contractions every contractors induced, % represented percentage of contractions every contractors induced to 60 mmol/L high K^+^ solution.
